CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
for 12 weeks, to reduce key markers of inflammation related to CVD risk, such as IL-6 and IL-18, in approximately 24 people with known heart ...
Phase 2
Jacksonville, Florida, United States and 8 other locations
This study is testing a potential new medicine, NNC6019-0001, for people who have a heart disease due to TTR amyloidosis.The study ...
Phase 2
Jacksonville, Florida, United States and 30 other locations
of this study is to evaluate the safety and effectiveness of tovinontrine compared to placebo to lower NT-proBNP in patients with chronic heart...
Phase 2
Jacksonville, Florida, United States and 13 other locations
of this study is to evaluate the safety and effectiveness of tovinontrine compared to placebo to lower NT-proBNP in patients with chronic heart...
Phase 2
Jacksonville, Florida, United States and 14 other locations
Multi-center, global, prospective, non-randomized, interventional, pre-market trial. All subjects enrolled with receive the study device.
Jacksonville, Florida, United States of America and 84 other locations
This trial will evaluate Orbital Atherectomy compared to conventional balloon angioplasty technique for the treatment of severely calcified lesions p...
Jacksonville, Florida, United States and 103 other locations
This study will test a medicine, NNC6019-0001, for people who have a heart disease due to TTR amyloidosis. It will look at how safe ...
Phase 2
Jacksonville, Florida, United States and 24 other locations
2.5) device during high-risk PCI in patients with reduced left-sided heart function will result in an improvement in symptoms, heart...
Jacksonville, Florida, United States and 126 other locations
This study will look at the effects of CagriSema on cardiovascular events (for example heart attack and stroke) in people living with cardio...
Phase 3
Fleming Island, Florida, United States and 576 other locations
This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults wi...
Phase 3
Jacksonville, Florida, United States and 851 other locations
Clinical trials
Research sites
Resources
Legal